USE OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF SPASTICITY IN CHILDREN WITH CEREBRAL PALSY
Journal Title: Acta Medica Medianae - Year 2011, Vol 50, Issue 2
Abstract
Cerebral palsy has an incidence of about 1-2 per 1000 live births, and in spite of the progress of neonatal medicine, it seems that the incidence will not subside in the near future. The most important characteristic of cerebral palsy is movement abnormality: spasticity, chorea, athetosis, ataxia, dystonia, as well as their different combinations. About 70% of children who suffer from cerebral palsy also suffer from some form of spasticity. Spasticity is a type of muscle hypertonicity characterized by rapid increase in resistance to passive stretching of muscles. The interest for botulinum toxin application in the treatment of spasticity has dramatically increased in the last 10 years. Botulinum toxin is the most powerful neurotoxin that is found in nature. It is produced by anaerobic bacteria – clostridium botulinum. It is produced in eight serotypes of which type A is the most commonly used. Botulinum toxin blocks neuromuscular transmission and causes irreversible weakness of the treated muscle. It has been used since 1993 in the treatment of cerebral palsy in children. The toxin effect is permanent and it results in irreversible denervation. Functional recovery is possible after 2-4 months, due to sprouting of nerve endings and the formation of new synaptic contacts. Treatment with botulinum toxin is safe. Adverse effects are rare, temporary and completely reversible. Application of botulinum toxin prevents or reduces contractures and deformities, and thus delays or avoids surgical treatment. Yet, physical therapy, which prolongs and improves the effects of botulinum toxin, remains an essential and most important form of therapy in the treatment of children with cerebral palsy.
Authors and Affiliations
Ljiljana Lazić, Hristina Čolović, Olga Marinković, Marija Spalević, Anita Stanković, Dragan Zlatanović
Keywords
Related Articles
- EP ID EP155689
- DOI doi:10.5633/amm.2011.0212
- Views 100
- Downloads 0
MAGNETIC RESONANCE PRESENTATION OF INTRACRANIAL MENINGIOMAS
Magnetic resonance (MR) has become the most important imaging method in the diagnosis of intracranial meningeomas. The aim of this study was to present the characteristics of meningiomas. Thirty patients with histologi...
STATUS VITAMINA D KOD ŽENA SA POSTMENOPAUZALNOM OSTEOPOROZOM
Poremećaj statusa vitamina D može se manifestovati kao insuficijencija (nedostatak), nedovoljnost (deficijencija) i hipervitaminoza. Status vitamina D u organizmu određuje se merenjem nivoa 25(OH)D u serumu. Cilj našeg...
PTERIDINES - METABOLIC FUNCTIONS AND CLINICAL DISORDERS
Pteridines are widely distributed compounds in nature, associated with numerous important physiological functions. BH4 is classified as unconjugated pteridine distinct from folic acid and its metabolites folates represen...
Primarni pulmonarni horiokarcinom- prikaz Bolesnika
U literaturi je opisano svega dvadesetak primera primarnih pulmonarnih horiokarcinoma. Za razliku od gestacijskog horiokarcinoma, koji dobro reaguje na hemioterapiju i ima dobru prognozu, čak i u slučajevima kad se otkri...
ENZYMOCHEMICAL AND BIOCHEMICAL CHANGES IN THE LIVER OF RATS INDUCED BY FURFURAL
In today's industrial expansion of the chemical products, the liver is becoming increasingly important. Furfural (C4C3OCHO) is a colorless liquid with pleasant aroma and it is partially soluble in water (8, 3% of weight)...